Search

Your search keyword '"O'Brien, Eoin"' showing total 1,575 results

Search Constraints

Start Over You searched for: Author "O'Brien, Eoin" Remove constraint Author: "O'Brien, Eoin"
1,575 results on '"O'Brien, Eoin"'

Search Results

1. Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial

3. Devices for Home Blood Pressure Monitoring

4. Guidelines for Home Blood Pressure Monitoring

5. Home Versus Ambulatory Blood Pressure Monitoring

6. Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial

7. Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial

9. Meta-analysis of genome-wide association studies of HDL cholesterol response to statins

11. Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

13. Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.

14. Isolated Diastolic Hypertension in the IDACO Study: An Age-Stratified Analysis Using 24-Hour Ambulatory Blood Pressure Measurements

16. Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension

18. Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A2 formation and with cardiovascular event free survival in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

19. Seasonal variation in blood pressure: Evidence, consensus and recommendations for clinical practice. Consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability

22. Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure

23. Author Response: Extensive remodelling of the cell wall during the development of Staphylococcus aureus bacteraemia

24. Extensive remodelling of the cell wall during the development of Staphylococcus aureus bacteraemia

25. European Society of Hypertension recommendations for the validation of cuffless blood pressure measuring devices: European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability

26. Extensive re-modelling of the cell wall during the development of Staphylococcus aureus bacteraemia

30. Home Versus Ambulatory Blood Pressure Monitoring

31. Guidelines for Home Blood Pressure Monitoring

32. Devices for Home Blood Pressure Monitoring

35. Reply

37. Lancet commission on hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure

38. Outcome-Driven Thresholds for Ambulatory Blood Pressure Based on the New American College of Cardiology/American Heart Association Classification of Hypertension

39. May Measurement Month 2021: an analysis of blood pressure screening results from the UK and Republic of Ireland

40. The contribution of competing mechanisms in stroke despite anticoagulation in patients with atrial fibrillation

42. Observer Agreement on Computed Tomography Perfusion Imaging in Acute Ischemic Stroke

44. Frequency and Prognosis of Treated Hypertensive Patients According to Prior and New Blood Pressure Goals: Post Hoc Analysis of the Spanish Ambulatory Blood Pressure Monitoring Registry

46. Recommendations and Practical Guidance for performing and reporting validation studies according to the Universal Standard for the validation of blood pressure measuring devices by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO)

47. Extensive re-modelling of the cell wall during the development ofStaphylococcus aureusbacteraemia

48. sj-docx-1-eso-10.1177_23969873231168367 – Supplemental material for The contribution of competing mechanisms in stroke despite anticoagulation in patients with atrial fibrillation

49. sj-docx-2-eso-10.1177_23969873231168367 – Supplemental material for The contribution of competing mechanisms in stroke despite anticoagulation in patients with atrial fibrillation

50. Declaracion de posicion del Grupo de la Comision Lancet de Hipertension con respecto a la mejora mundial de las normas de exactitud para los dispositivos de medicion de la presion arterial

Catalog

Books, media, physical & digital resources